PMA device
ENDOTAK RELIANCE / RELIANCE 4-FRONT pace/sense defibrillation leads
Boston Scientific · Implantable Cardioverter Defibrillator (Non-Crt) (LWS, Class III) · First FDA decision Oct 12, 2000, newest Mar 6, 2026Ventricular arrhythmia and sudden cardiac arrest
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
6
Naming "ENDOTAK RELIANCE RELIANCE"
MAUDE reports
1
Brand "ENDOTAK RELIANCE RELIANCE", since 2015
PubMed studies
0
Mentioning "ENDOTAK RELIANCE RELIANCE"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ENDOTAK RELIANCE / RELIANCE 4-FRONT pace/sense defibrillation leads
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
P910073-S187 · Decided Mar 6, 2026 · 37 days after receipt · Normal 180 Day Track No User Fee
Device type: Implantable cardioverter defibrillator (non-CRT) (LWS) · Cardiology
P910073-S185 · Decided Feb 20, 2026 · 80 days after receipt · Normal 180 Day Track No User Fee
Device type: Implantable cardioverter defibrillator (non-CRT) (LWS) · Cardiology
- ENDOTAK RELIANCE/RELIANCE S STEROID ELUTING EXTENDABLE/RETRACTABLE HELIX ENDOCARDIAL DEFIBRILLATION LEADPMA supplement
P910073-S039 · Decided Jul 25, 2002 · 136 days after receipt · Normal 180 Day Track
Device type: Implantable cardioverter defibrillator (non-CRT) (LWS) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Cardioverter DefibrillatorsNational analysisReview closedCAG-00157R4Updated Nov 19, 2026
- Implantable Cardioverter Defibrillators (ICDs)National determinationOn the books20.4Updated Sep 28, 2026
- Implantable Cardioverter Defibrillators (ICDs)National analysisReview closedCAG-00157NUpdated Sep 15, 2026
- Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web BasedLocal determinationIn effectL34087CGS Administrators, LLCUpdated Aug 28, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R2Updated Nov 19, 2026
- Implantable Defibrillators - Clinical TrialsNational analysisReview closedCAG-00157RUpdated Sep 15, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R3Updated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "ENDOTAK RELIANCE RELIANCE", any status and sponsor, newest update first.
- Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation LeadPivotal-lookingCompleted
Boston Scientific CorporationPublic (BSX)
NCT00180297 · 215 participants · Start Apr 2005 · Primary completion Sep 2012
Device: Endotak Reliance G · For: Ventricular Tachycardia; Ventricular Fibrillation
Sites: Amiens, France; Angers, France; Besançon, France · 18 sites in all
Boston Scientific CorporationPublic (BSX)
NCT02652481 · 500 participants · Start Jan 2016 · Primary completion Apr 30, 2017
Device: ImageReady MR Conditional Defibrillation System · For: Magnetic Resonance Imaging
Sites: Huntsville, Alabama; Jonesboro, Arkansas; Pasadena, California · 57 sites in all
Boston Scientific CorporationPublic (BSX)
NCT00180349 · 904 participants · Start Dec 2004 · Primary completion Jul 2009
Device: Endotak Reliance · For: Ventricular Tachycardia; Ventricular Fibrillation
Sites: Amiens, France; Angers, France; Angoulème, France · 25 sites in all
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ENDOTAK RELIANCE RELIANCE", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code LWS
240,687 reports: 89,252 malfunction, 148,026 injury, 3,316 death
Newest reports for this brand
MW5154254 · Received Apr 24, 2024 · Event dated Dec 25, 2023
Device type: Implantable Cardioverter Defibrillator (Non-Crt) (LWS)
Patient problem as coded: Insufficient Information
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2325-2025 · Started Jul 24, 2025 · Posted by FDA Aug 20, 2025
Reason given: Affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. Most serious harm is death or need for cardiac resuscitation.
Cause as FDA categorized it: Component design/selection · Device type: Implantable Cardioverter Defibrillator (Non-Crt) (LWS)
Z-2326-2025 · Started Jul 24, 2025 · Posted by FDA Aug 20, 2025
Reason given: Affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. Most serious harm is death or need for cardiac resuscitation.
Cause as FDA categorized it: Component design/selection · Device type: Permanent Defibrillator Electrodes (NVY)
Z-2327-2025 · Started Jul 24, 2025 · Posted by FDA Aug 20, 2025
Reason given: Affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. Most serious harm is death or need for cardiac resuscitation.
Cause as FDA categorized it: Component design/selection · Device type: Permanent Defibrillator Electrodes (NVY)
Published research
The most relevant PubMed records for "ENDOTAK RELIANCE RELIANCE"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LWS.
- Evera MRI XT DR SureScan Model DDMB1D4Medtronic Cardiac Rhythm Disease Management · PMA 2022
- CurrentAbbott Medical · PMA 2026
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)Boston Scientific Corporation · PMA 2022
- Evera S Dr,s Vr Xt Dr, Xt Ve,icd'sMedtronic Cardiac Rhythm Disease Management · PMA 2016
- Gem III At ICDMedtronic, Inc. · PMA 2016
- EMBLEM S-ICD Electrode (Lead) Model 3501Boston Scientific Corporation · PMA 2026
- Entrust ICDMedtronic Cardiac Rhythm Disease Management · PMA 2014
- Sprint Quattro Secure S MRI Surescan Lead Model 6935M,SPRINT Quattro Secure MRI Surescan Lead Model 6947MMedtronic, Inc. · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.